Russell Gilchrist, DO
Interventional Pain Medicine · Hickory, NCNPI 1144293143
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,795 of the $2,775 with a category attached, or 64.7%. 4 manufacturers reported payments, led by Boston Scientific at 59.3% of the total. 2025 is the largest year on record at $1,388, more than ten times the $138 reported in 2019. That places this record below the midpoint for interventional pain medicine clinicians in NC, where the typical reported total is $2,787.
Across 110 payments — averaging $25.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Stryker$1K
- Pfizer$12
- Assertio Therapeutics, Inc.$11
What the payments were for
- Travel & lodging$97835%
- Food & beverage$1,79565%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 100 | $1,647 |
| Stryker | 8 | $1,104 |
| Pfizer | 1 | $12 |
| Assertio Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$931
How this compares
$2,775 in reported general payments places this provider in the 40th percentile of 45 interventional pain medicine providers in North Carolina.
See all interventional pain medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 1,011 | $11,757 |
| Baclofen | 277 | $3,306 |
| Pregabalin | 174 | $3,018 |
| Celecoxib | 67 | $2,375 |
| Diclofenac Sodium | 153 | $1,890 |
| Tizanidine Hcl | 134 | $1,551 |
| Duloxetine Hcl | 97 | $1,324 |
| Doxepin Hcl | 29 | $1,242 |
| Prednisone | 181 | $1,089 |
| Methocarbamol | 88 | $976 |
| Etodolac ErEtodolac | 12 | $832 |
| Meloxicam | 257 | $797 |
| Cyclobenzaprine Hcl | 128 | $549 |
| Etodolac | 11 | $499 |
| Ibuprofen | 33 | $358 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Hickory
- Timothy ChafinAhoskie$59K
- Robert WilsonSalisbury$37K
- John MansfieldAsheville$25K
- Erin ChaneyJacksonville$22K
- Kevin CostelloGreenville$22K
- Scott JohnstonJacksonville$20K
- Harsh GovilStatesville$19K
- Troy GingerichCharlotte$19K
- Brent HarkriderNew Bern$14K
- Carey-Walter ClossonCharlotte$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.